The molecular basis of β-thalassemia
- PMID: 23637309
- PMCID: PMC3633182
- DOI: 10.1101/cshperspect.a011700
The molecular basis of β-thalassemia
Abstract
The β-thalassemias are characterized by a quantitative deficiency of β-globin chains underlaid by a striking heterogeneity of molecular defects. Although most of the molecular lesions involve the structural β gene directly, some down-regulate the gene through distal cis effects, and rare trans-acting mutations have also been identified. Most β-thalassemias are inherited in a Mendelian recessive fashion but there is a subgroup of β-thalassemia alleles that behave as dominant negatives. Unraveling the molecular basis of β-thalassemia has provided a paradigm for understanding of much of human genetics.
Figures




References
-
- Andersson BA, Wering ME, Luo HY, Basran RK, Steinberg MH, Smith HP, Chui DH 2007. Sickle cell disease due to compound heterozygosity for Hb S and a novel 7.7-kb β-globin gene deletion. Eur J Haematol 78: 82–85 - PubMed
-
- Arjona SN, Maldonado Eloy-Garcia J, Gu L-H, Smetanina NS, Huisman THJ 1996. The dominant β-thalassaemia in a Spanish family is due to a frameshift that introduces an extra CGG codon (=arginine) at the 5′ end of the second exon. Br J Haematol 93: 841–844 - PubMed
-
- Badens C, Mattei MG, Imbert AM, Lapoumérouliee C, Martini N, Michel G, Lena-Russo D 2002. A novel mechanism for thalassaemia intermedia. Lancet 359: 132–133 - PubMed
-
- Baiget M, Gomez Pereira C, Jue DL, Johnson MH, McGuffey JE, Moo-Penn WF 1986. A case of hemoglobin Indianapolis [β112(G14) Cys → Arg] in an individual from Cordoba, Spain. Hemoglobin 10: 483–494 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical